References
1. Eiland E, Nzerue C, Faulkner M. Preeclampsia 2012. J Pregnancy2012; 2012: 586578.
2. Fox KA, Longo M, Tamayo E, Kechichian T, Bytautiene E, Hankins GD, Saade GR, Costantine MM. Effects of pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia. Am J Obstet Gynecol 2011; 205: 366 e361-365.
3. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 122: 33-39.
4. Yu XD, Branch DW, Karumanchi SA, Zhang J. Preeclampsia and retinopathy of prematurity in preterm births. Pediatrics 2012; 130: e101-107.
5. Antonios TF, Raghuraman RP, D’Souza R, Nathan P, Wang D, Manyonda IT. Capillary remodeling in infants born to hypertensive pregnancy: pilot study. Am J Hypertens 2012; 25: 848-853.
6. Taglauer ES, Fernandez-Gonzalez A, Willis GR, Reis M, Yeung V, Liu X, Prince LS, Mitsialis SA, Kourembanas S. Antenatal Mesenchymal Stromal Cell Extracellular Vesicle Therapy Prevents Preeclamptic Lung Injury in Mice. American Journal of Respiratory Cell and Molecular Biology ; 0: null.
7. Thébaud B. Preempting Bronchopulmonary Dysplasia: Time to Focus on the Placenta? American Journal of Respiratory Cell and Molecular Biology ; 0: null.
8. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 279: L600-607.
9. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 2002; 283: L555-562.
10. Tang J-R, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. American Journal of Physiology-Lung Cellular and Molecular Physiology 2012; 302: L36-L46.
11. Yang WC, Chen CY, Chou HC, Hsieh WS, Tsao PN. Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia. Pediatr Neonatol 2015; 56: 382-385.
12. Mirzakhani H, Carey VJ, McElrath TF, Qiu W, Hollis BW, O’Connor GT, Zeiger RS, Bacharier L, Litonjua AA, Weiss ST. Impact of Preeclampsia on the Relationship between Maternal Asthma and Offspring Asthma. An Observation from the VDAART Clinical Trial. Am J Respir Crit Care Med 2019; 199: 32-42.
13. Stokholm J, Sevelsted A, Anderson UD, Bisgaard H. Preeclampsia Associates with Asthma, Allergy, and Eczema in Childhood. Am J Respir Crit Care Med 2017; 195: 614-621.
14. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122-1131.
15. Castillo A, Llapur CJ, Martinez T, Kisling J, Williams-Nkomo T, Coates C, Tepper RS. Measurement of single breath-hold carbon monoxide diffusing capacity in healthy infants and toddlers. Pediatr Pulmonol 2006; 41: 544-550.
16. Feher A, Castile R, Kisling J, Angelicchio C, Filbrun D, Flucke R, Tepper R. Flow limitation in normal infants: a new method for forced expiratory maneuvers from raised lung volumes. J Appl Physiol1996; 80: 2019-2025.
17. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med 2005; 172: 1463-1471.
18. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology 2020; 135: e237-e260.
19. Sengupta P. The Laboratory Rat: Relating Its Age With Human’s.Int J Prev Med 2013; 4: 624-630.
20. Doyle LW, Ranganathan S, Haikerwal A, Cheong JLY, Victorian Infant Collaborative Study G. Associations of Preeclampsia with Expiratory Airflows in School-Age Children Born Either at <28 Weeks or Weighing <1000 g. J Pediatr 2019; 209: 39-43 e32.
21. Nixon PA, Washburn LK, O’Shea TM. Antenatal steroid exposure and pulmonary outcomes in adolescents born with very low birth weight.Journal of Perinatology 2013; 33: 806-810.
22. Pole JD, Mustard CA, To T, Beyene J, Allen AC. Antenatal steroid therapy for fetal lung maturation: is there an association with childhood asthma? J Asthma 2009; 46: 47-52.
23. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319: 1112-1117.
24. Balinotti JE, Chakr VC, Tiller C, Kimmel R, Coates C, Kisling J, Yu Z, Nguyen J, Tepper RS. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med 2010; 181: 1093-1097.
25. Fitzgerald NM, Kennedy B, Fitzgerald DA, Selvadurai H. Diffusion capacity of carbon monoxide (DLCO) pre- and post-exercise in children in health and disease. Pediatr Pulmonol 2014; 49: 782-789.